GB1198301A - Perfluoroalkylsulfonamides - Google Patents

Perfluoroalkylsulfonamides

Info

Publication number
GB1198301A
GB1198301A GB47927/67A GB4792767A GB1198301A GB 1198301 A GB1198301 A GB 1198301A GB 47927/67 A GB47927/67 A GB 47927/67A GB 4792767 A GB4792767 A GB 4792767A GB 1198301 A GB1198301 A GB 1198301A
Authority
GB
United Kingdom
Prior art keywords
aqueous
sulphonamides
signifies
oct
heteroatom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB47927/67A
Inventor
Joseph Kenneth Harrington
Donald Charles Kvam
Arthur Mendel
Jerry Earl Robertson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
Minnesota Mining and Manufacturing Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minnesota Mining and Manufacturing Co filed Critical Minnesota Mining and Manufacturing Co
Publication of GB1198301A publication Critical patent/GB1198301A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • C07D241/40—Benzopyrazines
    • C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/02—Ortho- or ortho- and peri-condensed systems
    • C07C2603/04—Ortho- or ortho- and peri-condensed systems containing three rings
    • C07C2603/06—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members
    • C07C2603/10—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings
    • C07C2603/12—Ortho- or ortho- and peri-condensed systems containing three rings containing at least one ring with less than six ring members containing five-membered rings only one five-membered ring
    • C07C2603/18—Fluorenes; Hydrogenated fluorenes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

1,198,301. Sulphonamide compositions. MINNESOTA MINING & MFG. CO. 20 Oct., 1967 [21 Oct., 1966], No. 47928/67. Headings A5B and A5E. [Also in Division C2] Anti-inflammatory, analgesic, antipyretic and antifibrinolytic, and antimicrobial, e.g. antiparasitic, antibacterial and antifugal, pesticidal, e.g. insecticidal and nematocidal and plant growth regulative penfluoralkylsulphonamides are of the general formula: R f SO 2 NR 2 R 3 ; wherein R f signifies a C 1-8 perfluoroalkyl group, R 2 signifies a hydrogen atom, a C 1-6 alkyl group or a cation (includes ammonium and substituted ammonium cations) and R 3 signifies a heteroatom containing organic group (the heteroatom can occur in a heterocyclic ring or in the form of an acylic grouping, e.g. in substituents of rings or in aliphatic groups) which is bonded to the nitrogen atom in the foregoing formula through an aromatic ring therein (includes aromatic heterocyclic). Pharmaceutical preparations in the form of aqueous solutions or as suspensions in an aqueous or non-aqueous suspending agent, e.g. gum acacia and containing the above sulphonamides can be administered orally or injected subcutaneously or intramuscularly. The sulphonamides may also 'be administered in the form of capsules, tablets, powders, sterile solutions of water or other solvents or other dosage forms in association with conventional diluents and adjuvants as well as other tableting aids and fillers. For application to plants the sulphonamides can be finely divided in an aqueous suspension and other agents may also be incorporated therein. Dry powders can also be utilized.
GB47927/67A 1966-10-21 1967-10-20 Perfluoroalkylsulfonamides Expired GB1198301A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US58833866A 1966-10-21 1966-10-21

Publications (1)

Publication Number Publication Date
GB1198301A true GB1198301A (en) 1970-07-08

Family

ID=24353436

Family Applications (1)

Application Number Title Priority Date Filing Date
GB47927/67A Expired GB1198301A (en) 1966-10-21 1967-10-20 Perfluoroalkylsulfonamides

Country Status (5)

Country Link
BR (1) BR6794063D0 (en)
CH (1) CH513136A (en)
DE (1) DE1668420B2 (en)
FR (1) FR1579473A (en)
GB (1) GB1198301A (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548547B1 (en) 1998-07-08 2003-04-15 Aventis Pharma Deutschland Gmbh Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators
WO2006078283A3 (en) * 2004-04-30 2006-10-12 Genentech Inc Quinoxaline inhibitors of hedgehog signalling
US8722702B2 (en) 2006-11-22 2014-05-13 Plexxikon Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US8741920B2 (en) 2009-08-03 2014-06-03 Hoffmann-La Roche, Inc. Process for the manufacture of pharmaceutically active compounds
US8865735B2 (en) 2011-02-21 2014-10-21 Hoffman-La Roche Inc. Solid forms of a pharmaceutically active substance
AU2012200933B2 (en) * 2005-06-22 2015-04-30 Plexxikon, Inc. Pyrrolo [2, 3-B] pyridine derivatives as protein kinase inhibitors
US9096593B2 (en) 2009-11-06 2015-08-04 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
EP2395004B1 (en) * 2005-06-22 2016-01-20 Plexxikon Inc. Pyrrolo [2,3-b]pyridine derivatives as protein kinase inhibitors
US9447089B2 (en) 2009-04-03 2016-09-20 Plexxikon Inc. Compositions and uses thereof
US9469640B2 (en) 2007-07-17 2016-10-18 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
US9624213B2 (en) 2011-02-07 2017-04-18 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
EP3760615A4 (en) * 2018-02-27 2021-07-14 Nippon Soda Co., Ltd. Heteroaryl sulfonamide compound and pest control agent

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3661990A (en) * 1970-04-13 1972-05-09 Riker Laboratories Inc N-alkylsulfonyl benzoylhaloalkylsulfonanilides
US3647874A (en) * 1970-04-13 1972-03-07 Riker Laboratories Inc N-cyanobenzoylhaloalkylsulfonanilides
US3972926A (en) * 1971-01-04 1976-08-03 Riker Laboratories, Inc. Substituted trifluoromethanesulfonanilides
US3981914A (en) * 1971-08-03 1976-09-21 Minnesota Mining And Manufacturing Company N-alkylsulfonylperfluoroalkanesulfonanilides
US4005141A (en) 1972-07-03 1977-01-25 Minnesota Mining And Manufacturing Company Perfluoroalkylsulfonamidoaryl compounds
US3996277A (en) 1974-11-14 1976-12-07 Minnesota Mining And Manufacturing Company 4-Methylthio-2-trifluoromethylmethanesulfonanilide and derivatives thereof
EG16122A (en) * 1981-08-10 1987-04-30 Sumitomo Chemical Co Trifluoromethanesulfonanilide derivatives,their production and herbicides containing them as active ingredients
DE3834704A1 (en) * 1988-10-07 1990-06-07 Schering Ag Fluorosubstituted benzene derivatives
US20070238700A1 (en) * 2006-04-10 2007-10-11 Winzenberg Kevin N N-phenyl-1,1,1-trifluoromethanesulfonamide hydrazone derivative compounds and their usage in controlling parasites

Cited By (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6809089B2 (en) 1998-07-08 2004-10-26 Aventis Pharma Deutschland Gmbh Sulfonylaminocarboxylic acid N-arylamides as guanylate cyclase activators
US7351703B2 (en) 1998-07-08 2008-04-01 Sanofi-Aventis Deutschland Gmbh Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators
US6548547B1 (en) 1998-07-08 2003-04-15 Aventis Pharma Deutschland Gmbh Sulfonylamino carboxylic acid N-arylamides as guanylate cyclase activators
WO2006078283A3 (en) * 2004-04-30 2006-10-12 Genentech Inc Quinoxaline inhibitors of hedgehog signalling
JP2007535569A (en) * 2004-04-30 2007-12-06 ジェネンテック，インコーポレイティド Quinoxaline inhibitors of hedgehog signaling
AU2005325267B2 (en) * 2004-04-30 2010-11-04 Curis Inc. Quinoxaline inhibitors of the hedgehog signalling pathway
US8273743B2 (en) 2004-04-30 2012-09-25 Curis, Inc. Quinoxaline inhibitors of the hedgehog signalling
CN101018783B (en) * 2004-04-30 2012-11-21 遗传技术研究公司 Quinoxaline inhibitors of the HEDGEHOG signalling pathway
AU2012200933B2 (en) * 2005-06-22 2015-04-30 Plexxikon, Inc. Pyrrolo [2, 3-B] pyridine derivatives as protein kinase inhibitors
EP2395004B1 (en) * 2005-06-22 2016-01-20 Plexxikon Inc. Pyrrolo [2,3-b]pyridine derivatives as protein kinase inhibitors
US9487515B2 (en) 2006-11-22 2016-11-08 Plexxikon Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US9169250B2 (en) 2006-11-22 2015-10-27 Plexxikon Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US8722702B2 (en) 2006-11-22 2014-05-13 Plexxikon Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US9469640B2 (en) 2007-07-17 2016-10-18 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
US9844539B2 (en) 2007-07-17 2017-12-19 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
US10426760B2 (en) 2007-07-17 2019-10-01 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
US9447089B2 (en) 2009-04-03 2016-09-20 Plexxikon Inc. Compositions and uses thereof
US9663517B2 (en) 2009-04-03 2017-05-30 Plexxikon Inc. Compositions and uses thereof
US8741920B2 (en) 2009-08-03 2014-06-03 Hoffmann-La Roche, Inc. Process for the manufacture of pharmaceutically active compounds
US9096593B2 (en) 2009-11-06 2015-08-04 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
US9624213B2 (en) 2011-02-07 2017-04-18 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
US11337976B2 (en) 2011-02-07 2022-05-24 Plexxikon Inc. Compounds and methods for kinase modulation, and indications therefor
US8865735B2 (en) 2011-02-21 2014-10-21 Hoffman-La Roche Inc. Solid forms of a pharmaceutically active substance
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
US9695169B2 (en) 2012-05-31 2017-07-04 Plexxikon Inc. Synthesis of heterocyclic compounds
EP3760615A4 (en) * 2018-02-27 2021-07-14 Nippon Soda Co., Ltd. Heteroaryl sulfonamide compound and pest control agent

Also Published As

Publication number Publication date
BR6794063D0 (en) 1973-09-18
DE1668420A1 (en) 1970-06-25
FR1579473A (en) 1969-08-29
DE1668420B2 (en) 1976-11-25
CH513136A (en) 1971-09-30

Similar Documents

Publication Publication Date Title
GB1198301A (en) Perfluoroalkylsulfonamides
GB1178034A (en) Hydroxy-Cyclohexylamines
GB1434830A (en) 5-6-benzene ring substituted benzimidazole-2-carbamate derivatives having anthelmintic activity
GB1228736A (en)
GB1411583A (en) Aminophenyl-substituted alkyl-heterocyclic derivatives and processes for producing them
IL43722A (en) 2-aminomethyleneindanones and pharmaceutical compositions containing them
GB1456627A (en) Pyridobenzodiazepinones
GB1450211A (en) 5-methylthiopyrimidines their preparation and use
ES8800235A1 (en) Syn-isomer of 7-substituted-3-vinyl-3-cephem compounds, processes for production thereof and pharmaceutical compositions containing them.
GB1530074A (en) Rho-acetamidophenol derivatives the preparation thereof and the use of such derivatives as therapeutic agents
GB1195199A (en) Improvements in Compositions comprising Insulin.
ES427078A1 (en) Antimicrobial preparations
ES462229A1 (en) C3-carboxamido derivatives of vinblastine and alkaloids
GB1262292A (en) Novel thiazoline derivatives, the preparation thereof and compositions containing the same
GB1131164A (en) Novel halogen-substituted tetrahydroquinazoline derivatives, their preparation and compositions containing them
GB1296802A (en)
ES8300755A1 (en) Imidazole derivatives, their preparation and pharmaceutical compositions containing them.
GB1073521A (en) Indole derivatives
ES476529A1 (en) 3-Aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them.
GB1195319A (en) Alkyl Sulfate Salts of 1-(p-Chlorobenzhydryl)-4-Methylhomopiperazines
GB1143779A (en)
GB1354734A (en) Pharmaceutical compositions comprising aminoguanidine derivatives
IE39639B1 (en) N-substituted cycloserine compounds
GB1050565A (en)
SE7501871L (en)

Legal Events

Date Code Title Description
PS Patent sealed
429A Application made for amendment of specification (sect. 29/1949)
429H Application (made) for amendment of specification now open to opposition (sect. 29/1949)
429D Case decided by the comptroller ** specification amended (sect. 29/1949)
PE20 Patent expired after termination of 20 years